NPI: 1487629382 · VISALIA, CA 93277 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/22/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/22/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| DVA RENAL HEALTHCARE INC | SELLS | AZ | $7.17M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,011 | $1.96M |
| 2019 | 14,410 | $1.03M |
| 2020 | 8,083 | $917K |
| 2021 | 6,313 | $1.18M |
| 2022 | 8,225 | $1.18M |
| 2023 | 15,216 | $1.63M |
| 2024 | 14,504 | $1.32M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 59,411 | 4,572 | $8.87M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 8,045 | 537 | $150K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,014 | 674 | $63K |
| J1756 | Injection, iron sucrose, 1 mg | 2,504 | 881 | $56K |
| A4657 | Syringe, with or without needle, each | 2,937 | 1,426 | $49K |
| 0250 | 3,787 | 305 | $29K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,851 | 352 | $6K |
| 83970 | 841 | 714 | $2K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 41 | 24 | $1K |
| 90674 | 126 | 114 | $585.10 | |
| G0008 | Administration of influenza virus vaccine | 180 | 169 | $461.40 |
| 82728 | 424 | 380 | $426.26 | |
| 83550 | 301 | 249 | $280.42 | |
| 85041 | 847 | 706 | $242.50 | |
| 83540 | 485 | 431 | $208.47 | |
| 90662 | 13 | 12 | $191.32 | |
| 85048 | 798 | 678 | $163.83 | |
| 90661 | 22 | 22 | $78.91 | |
| 85045 | 19 | 13 | $0.00 | |
| 82607 | 13 | 13 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 75 | 55 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 14 | 14 | $0.00 |
| 82746 | 14 | 14 | $0.00 |